{
  "id": 18109474,
  "title": "Zydus Q2 FY27 slides: 29% revenue growth masks margin pressure",
  "url": "https://urgent.news/2026/11/04/zydus-q2-fy27-slides-29-revenue-growth-masks-margin-pressure",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-04T11:15:37.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/zydus-q2-fy27-slides-29-revenue-growth-masks-margin-pressure-93CH-4998391"
  },
  "original_language": "en",
  "account": "Zydus Lifesciences Limited reported a 29% year-over-year increase in consolidated revenues to Rs. 79,096 million for the second quarter of fiscal 2027, but faced declining net profit and margin compression. Shares fell 4.08% to $1,190 following the presentation. EBITDA margin held at 24%, while net profit dropped 26.6% to Rs. 9,255 million. The company's revenue growth was broad-based, with pharmaceutical business accounting for 83% of total sales and growing 22% year-over-year. North America formulations led revenue contribution at 43% of total sales, growing 21% year-over-year. India branded formulations achieved 19% growth, outperforming the broader market. Consumer Wellness and International Markets also showed strong growth. R&D investment totaled Rs. 6,573 million, and organic capital expenditure was Rs. 4,655 million. Despite profitability pressure, Zydus continued to invest in future growth drivers.",
  "summary": null,
  "key_points": [
    "Zydus revenues grew 29% YoY to Rs. 79,096 million in Q2 FY27",
    "EBITDA margin remained steady at 24%, but net profit fell 26.6%",
    "North America formulations contributed 43% of sales, up 21% YoY"
  ],
  "editors_take": "Aggressive spending on research and capital expenditures is eating into bottom-line returns, signaling that Zydus is prioritizing long-term expansion over immediate profitability despite strong top-line growth.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}